← Back to Search

Behavioral Intervention

Text Message Education for Heart Disease in HIV/AIDS

N/A

Recruiting

Led By Megan McLaughlin, MD, MPH

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 40 years of age

Be older than 18 years old

Must not have

Existing clinical atherosclerotic cardiovascular disease (ASCVD)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will explore if text messages can reduce heart disease risk in people living with HIV.

Who is the study for?

This trial is for English-speaking adults over 40 years old who are living with HIV but do not have existing cardiovascular disease. Participants must own a smartphone and be willing to provide informed consent. Pregnant individuals cannot participate.

What is being tested?

The TEACH-HIV trial is testing whether educational text messages can help reduce the risk of heart disease in people with HIV. The effectiveness of these digital messages will be evaluated over time.

What are the potential side effects?

Since this intervention involves receiving educational text messages, there are no direct medical side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 40 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have heart disease related to artery blockage.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of participants with controlled blood pressure

Secondary study objectives

Blood sugar control

Body mass index

Cholesterol

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ArmExperimental Treatment1 Intervention

The intervention arm will receive education about HIV and heart disease risk via mobile phone text messages for up to 6 months. They will receive the text messages 3-5 times per week. The messages will include information about HIV and risk of heart disease and information about how to reduce heart disease risk. The intervention arm will also receive brief monthly surveys via a digital research platform.

Group II: Control ArmActive Control1 Intervention

The control arm will not receive the educational text messages. They will receive brief monthly surveys via a digital research platform.

0 / 2Eligibility criteria met